Merlin waves his biotechnological wand

April 3, 1998

Merlin Ventures, the biotechnology investment firm set up by academic-turned-entrepreneur Chris Evans, is pumping Pounds 10 million into three of its firms. ReNeuron, set up last year, will get Pounds 5 million for research at the Institute of Psychiatry, part of King's College London, on treatments for strokes, Alzheimer's and Parkinson's disease, and genetic disorders such as Huntingdon's disease.

Microscience, a spin-off of the Royal Postgraduate Medical School, will get Pounds 2.5 million for work on antimicrobial vaccines and drugs. Eurogene will get Pounds 3 million for work on cardiovascular disease at University College London and at Finland's Virtanen Institute.

Please login or register to read this article.

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments